D. Boring

发表

Structural requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groups.

A. Makriyannis, A. Howlett, S. Lin, 1998, Prostaglandins, leukotrienes, and essential fatty acids.

Population Pharmacokinetic Model for Cancer Chemoprevention With Sulindac in Healthy Subjects

S. Mandrekar, E. Szabo, J. Reid, 2013, Journal of clinical pharmacology.

Green Tea Extract-Induced Lethal Toxicity in Fasted but Not in Nonfasted Dogs

Kuei-Meng Wu, D. Boring, Jiaqin Yao, 2011, International journal of toxicology.

Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors.

K. Jacobson, G. Stiles, X. Ji, 1991, Bioconjugate chemistry.

Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer

S. Libutti, P. Wingfield, R. Shoemaker, 2022, PloS one.

Forskolin carbamates: binding and activation studies with type I adenylyl cyclase

Wei-Jen Tang, K. Seamon, D. Boring, 1996 .

Human-bacteria nitric oxide cycles in HIV-1 infection.

H. Haverkos, D. Boring, H. Zhang, 2002, Medical hypotheses.

Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo.

K. Kashfi, N. Nath, M. Chattopadhyay, 2012, Biochemical pharmacology.

Forskolin carbamates: binding and activation studies with type I adenylyl cyclase.

K. Seamon, W. J. Tang, D. Boring, 1996, Journal of medicinal chemistry.

Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy

V. Steele, L. Minasian, A. Bode, 2015, Cancer Prevention Research.

Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.

A. Barsegian, K. Kashfi, N. Nath, 2012, Biochemical pharmacology.

Lack of Efficacy of the Statins Atorvastatin and Lovastatin in Rodent Mammary Carcinogenesis

V. Steele, J. Ruppert, R. Lubet, 2009, Cancer Prevention Research.

Abstract 4608: Hydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression

K. Kashfi, J. Crowell, M. Chattopadhyay, 2011 .

Modulation of stress genes expression profile by nitric oxide-releasing aspirin in Jurkat T leukemia cells.

K. Kashfi, N. Nath, J. Crowell, 2010, Biochemical pharmacology.

Cerebrodiene, arachidonyl-ethanolamide, and hybrid structures: potential for interaction with brain cannabinoid receptors.

A. Howlett, D. Boring, B. Berglund, 1996, Prostaglandins, leukotrienes, and essential fatty acids.

Investigation of structural analogs of prostaglandin amides for binding to and activation of CB1 and CB2 cannabinoid receptors in rat brain and human tonsils.

A. Howlett, D. Boring, B. Berglund, 1999, Advances in experimental medicine and biology.

Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid.

K. Rice, F. Potié, A. Howlett, 1994, Molecular pharmacology.

The Development and Adoption of Nonproprietary, Established, and Proprietary Names for Pharmaceuticals

Dan Boring, D. Boring, 1997 .

Preventive Effects of NSAIDs, NO-NSAIDs, and NSAIDs Plus Difluoromethylornithine in a Chemically Induced Urinary Bladder Cancer Model

V. Steele, A. Bode, Yan Lu, 2013, Cancer Prevention Research.

Chemopreventive Efficacy of Naproxen and Nitric Oxide–naproxen in Rodent Models of Colon, Urinary Bladder, and Mammary Cancers

V. Steele, L. Kopelovich, C. Rao, 2009, Cancer Prevention Research.

Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668

Rui Qin, Brent A Bauer, Sumithra J Mandrekar, 2011, Cancer Prevention Research.

Label-free global serum proteomic profiling reveals novel celecoxib-modulated proteins in familial adenomatous polyposis patients.

Ming Yi, Iqbal Unnisa Ali, Peter Greenwald, 2009, Cancer genomics & proteomics.

SR 13668 Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor

S. Mandrekar, E. Szabo, B. Bauer, 2011 .

Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect.

K. Kashfi, N. Nath, M. Chattopadhyay, 2012, Biochemical pharmacology.

NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S-nitrosylation.

K. Kashfi, J. Crowell, M. Chattopadhyay, 2010, Cancer letters.

Synthesis and biological activity of acetyl-protected hydroxybenzyl diethyl phosphates (EHBP) as potential chemotherapeutic agents.

K. Kashfi, N. Nath, J. Crowell, 2011, Bioorganic & medicinal chemistry letters.

Comparative Bioavailability of Sulindac in Capsule and Tablet Formulations

S. Mandrekar, W. Harmsen, E. Szabo, 2008, Cancer Epidemiology Biomarkers & Prevention.

Population Pharmacokinetic Model for Cancer Chemoprevention With Sulindac in Healthy Subjects

S. Mandrekar, E. Szabo, J. Reid, 2013, Journal of clinical pharmacology.